论文部分内容阅读
To understand the pathophysiologic significances of soluble Fas Ligand (sFasL) and soluble Fas receptor (sFas) in chronic congestive heart failure (CHF) and to determine the relationship of circulating levels of sFasL and sFas to the severity of CHF, the serum sFasL and sFas levels were evaluated in patients with CHF.
To understand the pathophysiologic significances of soluble Fas Ligand (sFasL) and soluble Fas receptor (sFas) in chronic congestive heart failure (CHF) and determine the relationship of circulating levels of sFasL and sFas to the severity of CHF, the serum sFasL and sFas levels were evaluated in patients with CHF.